Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04809740 · ClinicalTrials.gov registry record · NA

Evaluating the Implementation and Impact of Navigator-delivered ePRO System

A NA study of Cancer, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
7,500
Enrollment target
2
Study locations

NCT04809740 is a NA study of Cancer that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 7,500 participants, above the 3,479-participant average among 615 other Cancer trials with a reported enrollment target (116% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04809740, a NA study of Cancer, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
7,500 participants
Enrollment target
2
Study locations

Study Summary

1\) Evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites; 2) examine the barriers, facilitators, and implementation strategies used in implementing navigator-delivered Home ePRO; and 3) assess the impact of Home ePRO on clinical and utilization outcomes.

Conditions Studied

Interventions

  • OTHER Evaluate implementation of navigator-delivered Home ePRO for all cancer patients

Study Locations (2)

Alabama

  • University of Alabama at Birmingham - Birmingham
  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 7,500 participants
Start Date 2021-05-04
Est. Completion 2027-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04809740

The ClinicalTrials.gov registry entry for NCT04809740 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 7,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,479-participant average among 615 other Cancer trials with a reported enrollment target (116% higher). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Evaluate implementation of navigator-delivered Home ePRO for all cancer patients is the first listed.

NCT04809740 reports 2 study locations spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04809740 about?

NCT04809740 is a clinical study titled "Evaluating the Implementation and Impact of Navigator-delivered ePRO System". 1\) Evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites; 2) examine the barriers, facilitators, and implementation strategies used in implementing navigator-delivered Home ePRO; and 3) assess the impact of Home ePRO on clinical and utilizat...

What is the current status of trial NCT04809740?

This trial is currently recruiting. It is a NA study. The enrollment target is 7,500 participants. The study started on 2021-05-04. Estimated completion is 2027-01.

What conditions does trial NCT04809740 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT04809740?

The interventions under investigation include: Evaluate implementation of navigator-delivered Home ePRO for all cancer patients (OTHER).

Who is sponsoring clinical trial NCT04809740?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04809740 being conducted?

This trial has 2 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.